Institutional investors hold a majority ownership of MRK through the 75.94% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2015, these large investors purchased a net $9.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABERDEEN ASSET INVESTMENTS LTD. Bought 285.3 Thousand shares of Merck
STANDARD LIFE INVESTMENTS LTD. Bought 180.5 Thousand shares of Merck
STATE STREET GLOBAL ADVISORS LTD... Bought 107.8 Thousand shares of Merck